🔎 Trials Near Me

홈 › 비소세포폐암 › 위스콘신 › Milwaukee

WI Milwaukee의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 22개가 Milwaukee 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

피험자 모집 중3상
  • Froedtert Menomonee Falls Hospital, Menomonee Falls · 14마일 거리
  • ProHealth Waukesha Memorial Hospital, Waukesha · 17마일 거리
  • UW Cancer Center at ProHealth Care, Waukesha · 17마일 거리
  • 외 1개
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

피험자 모집 중3상
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital-Milwaukee Campus, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • 외 13개
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT04267848

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

피험자 모집 중1상
  • Exelixis Clinical Site #33, Milwaukee
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

피험자 모집 중3상
  • UW Cancer Center at ProHealth Care, Waukesha · 17마일 거리
  • ProHealth D N Greenwald Center, Mukwonago · 25마일 거리
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06498635

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

피험자 모집 중1상
  • Research Site, Milwaukee
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

피험자 모집 중3상
  • Froedtert Hospital/Medical College of Wisconsin, Milwaukee
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07222566

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

피험자 모집 중1상
  • Research Site, Milwaukee
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

피험자 모집 중3상
  • Aurora St. Luke's Medical Center, Milwaukee
  • Aurora Cancer Care-Grafton, Grafton · 20마일 거리
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

피험자 모집 중2상
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • 외 5개
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT03191149

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

피험자 모집 중3상
  • Medical College of Wisconsin, Milwaukee
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06890598

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

피험자 모집 중1/2상
  • Froedtert Hospital - Clinical Cancer Center, Milwaukee
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06914128

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • Medical College of Wisconsin, Milwaukee
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06561685

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

피험자 모집 중3상
  • Research Site, Milwaukee
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06350097

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

피험자 모집 중2상
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • 외 4개
18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

피험자 모집 중2상
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • 외 5개
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

피험자 모집 중2/3상
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • 외 5개
18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

피험자 모집 중관찰 연구
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • 외 10개
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

피험자 모집 중
  • Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
18세 이상 · 모든 성별 · 2026. 2. 19. 업데이트됨 · NCT02984761

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구
  • Massive Bio SYNERGY-AI site, Milwaukee
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)

피험자 모집 중2상
  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
18세 이상 · 모든 성별 · 2025. 10. 7. 업데이트됨 · NCT06305715

다른 도시의 비소세포폐암 시험

Milwaukee의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.